Rapid deployment valves: current position on the market and future directions

In the context of a rapidly evolving treatment paradigm for aortic valve stenosis, SU and RDV bioprostheses have demonstrated their value as reliable devices for surgical valve replacement. Continued clinical research will be essential to better delineate which patients may benefit most as part of an individualized, lifetime valve-management strategy.